Provided by Tiger Fintech (Singapore) Pte. Ltd.

Salarius Pharmaceuticals Inc

0.9899
-0.0001-0.01%
Post-market: 0.99000.0001+0.01%18:53 EDT
Volume:152.07K
Turnover:148.11K
Market Cap:2.11M
PE:-0.22
High:1.01
Open:0.9900
Low:0.8900
Close:0.9900
Loading ...
Jun 16, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 16, 2025

Major Issues Report

Form 8-K - Current report
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 17, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 27, 2024

Correspondence

Form CORRESP - Correspondence
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report